Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Nuclear Medicine

• Publication date

  2015-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2967/jnumed.114.149526PMID 25500827PMCID PMC6484861
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improving the Efficacy of Photoimmunotherapy (PIT) using a Cocktail of Antibody Conjugates in a Multiple Antigen Tumor Model

  2013cited by this paper
• Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.

  2013cited by this paper
• Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate.

  2012cited by this paper
• In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores

  2012cited by this paper
• Cancer radioimmunotherapy.

  2011cited by this paper
• Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules

  2011cited by this paper
• Antibody-drug conjugates: targeted drug delivery for cancer.

  2010cited by this paper
• Development of antibodies and chimeric molecules for cancer immunotherapy.

  2006cited by this paper
• Arming antibodies: prospects and challenges for immunoconjugates

  2005cited by this paper
• Pharmacokinetics of 111In- and 125I-labeled antiTac single-chain Fv recombinant immunotoxin.

  2000cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Immunotoxin therapy of cancer.

  1993cited by this paper
• Immunotoxin therapy of cancer.

  1993cited by this paper

• IR700DX-Based Antibody Conjugates: a Unique Tool for Targeted Cancer Phototherapy

  2026cites this paper
• An Overview of Target Membrane Proteins for Near-Infrared Photoimmunotherapy

  2025cites this paper
• Near-Infrared Photoimmunotherapy for The Treatment of Malignant Brain Tumors—The Present Challenges and Future Perspectives—

  2025cites this paper
• Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics

  2025cites this paper
• Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugates

  2025cites this paper
• Near-Infrared Photoimmunotherapy in Brain Tumors—An Unexplored Frontier

  2025cites this paper
• Prostate-Specific Membrane Antigen-Targeted NIR Phototheranostics for Prostate Cancer.

  2024cites this paper
• Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy

  2023cites this paper
• Near Infrared Photoimmunotherapy: A Review of Recent Progress and Their Target Molecules for Cancer Therapy

  2023cites this paper
• Near-infrared photoimmunotherapy and anti-cancer immunity.

  2023cites this paper
• Near-infrared photoimmunotherapy (NIR-PIT) of bone metastases.

  2023cites this paper
• A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer

  2022cites this paper
• Near-infrared photoimmunotherapy: design and potential applications for cancer treatment and beyond

  2022cites this paper
• Photodynamic therapy for prostate cancer: Recent advances, challenges and opportunities

  2022cites this paper
• Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment

  2022cites this paper
• Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers

  2022cites this paper
• Evaluation of Fluorescence Intensity and Antitumor Effect Using Real-Time Imaging in Photoimmunotherapy

  2022cites this paper
• A Photosensitized Singlet Oxygen (1O2) Toolbox for Bio-Organic Applications: Tailoring 1O2 Generation for DNA and Protein Labelling, Targeting and Biosensing

  2022cites this paper
• Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials

  2021cites this paper
• Near-InfraRed PhotoImmunoTherapy (NIR-PIT) for the local control of solid cancers: Challenges and potentials for human applications

  2021cites this paper
• PSMA-targeted low-molecular double conjugates for diagnostics and therapy.

  2021cites this paper
• Imaging modalities for monitoring acute therapeutic effects after near‐infrared photoimmunotherapy in vivo

  2021cites this paper
• Peptide-based assemblies as immune checkpoint inhibitor delivery systems for enhanced immunotherapy

  2021cites this paper
• Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers

  2021cites this paper
• Nanomedicine in cancer therapy: promises and hurdles of polymeric nanoparticles

  2021influential citation
• Near infrared photoimmunotherapy of cancer; possible clinical applications

  2021cites this paper
• Selective photokilling of colorectal tumors by near-infrared photoimmunotherapy with a GPA33-targeted single-chain antibody variable fragment conjugate.

  2020cites this paper
• Antibody Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers.

  2020cites this paper
• 新規癌治療法である近赤外光線免疫療法（NIR-PIT）

  2020cites this paper
• Site‐specific Bioconjugation and Convergent Click Chemistry Enhances Antibody–Chromophore Conjugate Binding Efficiency

  2020cites this paper
• Targeted photoimmunotherapy based on photosensitizer-antibody conjugates for multiple myeloma treatment.

  2020cites this paper
• Photodynamic therapy for prostate cancer- a narrative review.

  2020cites this paper
• An effective invasive therapeutic approach of fluoro-substituted zinc phthalocyanine derivatives as potential photosensitizer for prostate carcinoma

  2020cites this paper
• Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment

  2020cites this paper
• The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.

  2020cites this paper
• Near Infrared Photoimmunotherapy: Photo-Activatable Antibody-Drug Conjugates (ADCs).

  2019cites this paper
• Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations.

  2019cites this paper
• Targeting prostate cancer: Prostate‐specific membrane antigen based diagnosis and therapy

  2019cites this paper
• Photosensitizer Antibody-Drug Conjugates: Past, Present, and Future.

  2019cites this paper
• Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation.

  2019cites this paper
• Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors

  2019cites this paper
• Nanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma Cells

  2019cites this paper
• The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near Infrared Photoimmunotherapy (NIR-PIT).

  2019cites this paper
• PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery

  2019cites this paper
• P-glycoprotein targeted photodynamic therapy of chemoresistant tumors using recombinant Fab fragment conjugates.

  2018cites this paper
• Porphyrinoid biohybrid materials as an emerging toolbox for biomedical light management.

  2018cites this paper
• Molecular imaging of tumor photoimmunotherapy: Evidence of photosensitized tumor necrosis and hemodynamic changes.

  2018cites this paper
• Differences in Therapeutic Efficacy in Pancreatic Cancer Between Interstitial and Superficial Light Delivery Strategies in Targeted Photo Therapy

  2018cites this paper
• Differences in Therapeutic Efficacy in Pancreatic Cancer Between Interstitial and Superficial Light Delivery Strategies in Targeted Photo Therapy

  2018cites this paper
• Tumor uptake of pegylated diabodies: Balancing systemic clearance and vascular transport

  2018cites this paper
• Enhancing Anti-PD-1/PD-L1 Immune Checkpoint Inhibitory Cancer Therapy by CD276-Targeted Photodynamic Ablation of Tumor Cells and Tumor Vasculature.

  2018cites this paper
• Dual-Modality ImmunoPET/Fluorescence Imaging of Prostate Cancer with an Anti-PSCA Cys-Minibody

  2018cites this paper
• Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent.

  2018cites this paper
• Near-Infrared Photoimmunotherapy Targeting Prostate Cancer with Prostate-Specific Membrane Antigen (PSMA) Antibody

  2017cites this paper
• Targeted imaging in oncologic surgery : preclinical studies utilizing near-infrared fluorescence and radioactivity

  2017cites this paper
• Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.

  2017cites this paper
• A PSMA-targeted theranostic agent for photodynamic therapy.

  2017cites this paper
• Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti–CD44-Based NIR-PIT

  2017cites this paper
• PSMA ligands in prostate cancer - Probe optimization and theranostic applications.

  2017cites this paper
• Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy

  2017cites this paper
• Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts

  2017cites this paper
• Beyond the Barriers of Light Penetration: Strategies, Perspectives and Possibilities for Photodynamic Therapy

  2016cites this paper
• Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer

  2016cites this paper
• Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody

  2016cites this paper
• Near Infrared Photoimmunotherapy in a Transgenic Mouse Model of Spontaneous Epidermal Growth Factor Receptor (EGFR)-expressing Lung Cancer

  2016cites this paper
• Near infrared photoimmunotherapy of B‐cell lymphoma

  2016cites this paper
• EpCAM as multi-tumour target for near-infrared fluorescence guided surgery

  2016cites this paper
• Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen

  2016influential citation
• Near infrared photoimmunotherapy with an anti-mesothelin antibody

  2016cites this paper
• Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model.

  2016cites this paper
• Prostate Cancer Diagnosis Based on the Segmentation and Analysis of NIR Images Obtained Using Two PSMA-1 Based PDT Conjugates PSMA-1-Pc413 and PSMA-1-IR700

  2016cites this paper
• Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry

  2016cites this paper
• Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand

  2016cites this paper
• EGFR targeted nanobody–photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer

  2016cites this paper
• Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique.

  2016cites this paper
• Bioluminescence-Activated Deep-Tissue Photodynamic Therapy of Cancer

  2015cites this paper
• Prostate-specific membrane antigen as a target for cancer imaging and therapy.

  2015cites this paper
• Bioluminescence-Activated Deep-Tissue Photodynamic Therapy

  2015cites this paper
• Phthalocyanine-Biomolecule Conjugated Photosensitizers for Targeted Photodynamic Therapy and Imaging.

  2015cites this paper